Evolus, Inc.
EOLSDrugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How EOLS's past catalysts played out
Botulinum toxin, Type A
Glabellar Frown Lines
PrabotulinumtoxinA-Xvfs
Glabellar Frown Lines
Botulinum purified neurotoxin, Type A
Glabellar Frown Lines
DWP-450 (Botulinum purified neurotoxin, Type A)
Glabellar Frown Lines
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Botulinum toxin, Type A | Phase 3 | Glabellar Frown Lines | - | - |
PrabotulinumtoxinA-Xvfs | Phase 2 | Glabellar Frown Lines | - | - |
Botulinum purified neurotoxin, Type A | Phase 2 | Glabellar Frown Lines | - | - |
DWP-450 (Botulinum purified neurotoxin, Type A) | Phase 2 | Glabellar Frown Lines | - | - |
Frequently asked questions
What is in Evolus, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Evolus, Inc.'s (EOLS) pipeline across Phase 3, Phase 2. Its lead program is Botulinum toxin, Type A (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Evolus, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Evolus, Inc. (EOLS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track EOLS biotech catalysts?→
Add EOLS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Evolus, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.